Kexxtone

RSS
Suspended

This medicine is currently suspended from use in the European Union

monensin
MedicineVeterinarySuspended
  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Kexxtone has been suspended.

български (BG) (208.47 KB - PDF)

View

español (ES) (232.8 KB - PDF)

View

čeština (CS) (190.03 KB - PDF)

View

dansk (DA) (186.76 KB - PDF)

View

Deutsch (DE) (194.21 KB - PDF)

View

eesti keel (ET) (194.02 KB - PDF)

View

ελληνικά (EL) (234.33 KB - PDF)

View

français (FR) (215.01 KB - PDF)

View

italiano (IT) (187.58 KB - PDF)

View

latviešu valoda (LV) (218.33 KB - PDF)

View

lietuvių kalba (LT) (240.14 KB - PDF)

View

magyar (HU) (210.3 KB - PDF)

View

Malti (MT) (192.73 KB - PDF)

View

Nederlands (NL) (165.62 KB - PDF)

View

polski (PL) (200.09 KB - PDF)

View

português (PT) (239.67 KB - PDF)

View

română (RO) (213.47 KB - PDF)

View

slovenčina (SK) (220.17 KB - PDF)

View

slovenščina (SL) (210.32 KB - PDF)

View

Suomi (FI) (176.13 KB - PDF)

View

svenska (SV) (207.19 KB - PDF)

View

Product information

български (BG) (1.31 MB - PDF)

View

español (ES) (924.22 KB - PDF)

View

čeština (CS) (964.6 KB - PDF)

View

dansk (DA) (816.56 KB - PDF)

View

Deutsch (DE) (916.47 KB - PDF)

View

eesti keel (ET) (929.62 KB - PDF)

View

ελληνικά (EL) (1.32 MB - PDF)

View

français (FR) (933.71 KB - PDF)

View

hrvatski (HR) (945.9 KB - PDF)

View

íslenska (IS) (906.49 KB - PDF)

View

italiano (IT) (929.79 KB - PDF)

View

latviešu valoda (LV) (1.28 MB - PDF)

View

lietuvių kalba (LT) (1.24 MB - PDF)

View

magyar (HU) (1.04 MB - PDF)

View

Malti (MT) (1.29 MB - PDF)

View

Nederlands (NL) (916.96 KB - PDF)

View

norsk (NO) (904.87 KB - PDF)

View

polski (PL) (977.83 KB - PDF)

View

português (PT) (919.12 KB - PDF)

View

română (RO) (1.26 MB - PDF)

View

slovenčina (SK) (1002.66 KB - PDF)

View

slovenščina (SL) (1.21 MB - PDF)

View

Suomi (FI) (911.95 KB - PDF)

View

svenska (SV) (909.85 KB - PDF)

View

български (BG) (107.94 KB - PDF)

View

español (ES) (638.03 KB - PDF)

View

čeština (CS) (634.99 KB - PDF)

View

dansk (DA) (638.96 KB - PDF)

View

Deutsch (DE) (639.83 KB - PDF)

View

eesti keel (ET) (638.45 KB - PDF)

View

ελληνικά (EL) (676.6 KB - PDF)

View

français (FR) (638.55 KB - PDF)

View

hrvatski (HR) (615.51 KB - PDF)

View

íslenska (IS) (638.83 KB - PDF)

View

italiano (IT) (645.28 KB - PDF)

View

latviešu valoda (LV) (673.9 KB - PDF)

View

lietuvių kalba (LT) (674.49 KB - PDF)

View

magyar (HU) (657.27 KB - PDF)

View

Malti (MT) (681.14 KB - PDF)

View

Nederlands (NL) (638.65 KB - PDF)

View

norsk (NO) (638.56 KB - PDF)

View

polski (PL) (662.14 KB - PDF)

View

português (PT) (639.11 KB - PDF)

View

română (RO) (676.05 KB - PDF)

View

slovenčina (SK) (657.65 KB - PDF)

View

slovenščina (SL) (673.67 KB - PDF)

View

Suomi (FI) (636.89 KB - PDF)

View

svenska (SV) (638.3 KB - PDF)

View

Product details

Name of medicine
Kexxtone
Active substance
monensin (as monensin sodium)
International non-proprietary name (INN) or common name
monensin
Anatomical therapeutic chemical veterinary (ATCvet) code
QA16QA06

Pharmacotherapeutic group

Drugs for prevention and/or treatment of acetonemia

Authorisation details

EMA product number
EMEA/V/C/002235

Assessment history

This page was last updated on

Share this page